Telomir Pharmaceuticals Inc stock is traded at $0.481, with a volume of 481,516. It is down -1.96% in the last 24 hours and down -54.19% over the past month. Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.
Previous Close:
$0.4906
Open:
$0.4742
24h Volume:
481,516
Relative Volume:
2.02
Market Cap:
$35.44M
Revenue:
-
Net Income/Loss:
-$9.22M
P/E Ratio:
-
EPS:
-$0.2917
Net Cash Flow:
-$4.60M
1W Performance:
-15.92%
1M Performance:
-54.19%
6M Performance:
-61.83%
1Y Performance:
-65.64%
1-Day Range:
$0.4422$0.5172
1-Week Range:
$0.4422$0.71
52-Week Range:
$0.4422$1.58
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Name
Telomir Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
786-396-6723Address
100 SE 2ND ST, MIAMI, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS